Transcripts Abliva AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 12:00:00 2024-07-16 pm EDT			5-day change	1st Jan Change
0.2175 ^SEK	-4.40%		+8.75%	-11.41%

May. 30	Abliva Concludes Dosing in Mid-stage Study of Mitochondrial Disease Drug	MT
May. 30	Abliva AB Announces Completion of 24 Weeks of Dosing in Wave 1 of the Falcon Study of KL1333 in Primary Mitochondrial Disease	CI

Transcript : Abliva AB - Special Call	May. 21
Transcript : Abliva AB - Special Call	22-06-01
Transcript : Abliva AB Presents at BioStock Life Science Summit 2020, Nov-17-2020 01:05 PM	20-11-17

No results for this search